Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,619 | -48,557 | -146,962 | -132,594 | -79,727 |
| Depreciation Amortization | -3,694 | -1,611 | -1,664 | -1,286 | -964 |
| Accounts receivable | 15,000 | 15,000 | -15,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 106 | 75 | 2,038 | 507 | -513 |
| Other Working Capital | -19,448 | -6,316 | 2,682 | -9,211 | -19,098 |
| Other Operating Activity | 16,128 | 1,818 | 56,080 | 31,713 | 21,078 |
| Operating Cash Flow | $-82,527 | $-39,591 | $-102,826 | $-110,871 | $-79,224 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,091 | -7,402 | -34,480 | -22,855 | -14,777 |
| Purchase Of Investment | -526,860 | -422,704 | -189,151 | -143,647 | -114,477 |
| Sale Of Investment | 223,986 | 99,499 | 363,517 | 287,436 | 189,677 |
| Investing Cash Flow | $-314,965 | $-330,607 | $139,886 | $120,934 | $60,423 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -642 | -290 | -76 | -1,001 | -661 |
| Common Stock Issued | 355,810 | 354,046 | 4,268 | 3,259 | 3,125 |
| Financing Cash Flow | $355,168 | $353,756 | $4,192 | $2,258 | $2,464 |
| Beginning Cash Position | 115,777 | 115,777 | 74,525 | 74,524 | 74,524 |
| End Cash Position | 73,453 | 99,335 | 115,777 | 86,845 | 58,187 |
| Net Cash Flow | $-42,324 | $-16,442 | $41,252 | $12,321 | $-16,337 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,527 | -39,591 | -102,826 | -110,871 | -79,224 |
| Capital Expenditure | -12,091 | -7,402 | -34,480 | -22,855 | -14,777 |
| Free Cash Flow | -94,618 | -46,993 | -137,306 | -133,726 | -94,001 |